Core Viewpoint - Cell Press has launched a new open-access journal, Cell Press Blue, focusing on significant pioneering research in life sciences, physical sciences, medicine, sustainable development, and applied sciences [3] Group 1: Journal Overview - Cell Press Blue welcomes interdisciplinary research that connects biology, medicine, chemistry, physics, materials science, energy, environmental science, and sustainable development [3] - The journal will publish authoritative reviews and opinion articles to showcase emerging opportunities and reflect on the role of science in addressing major contemporary challenges [3] Group 2: Editorial Leadership - The editor-in-chief of Cell Press Blue is Dr. Andy Jobbins, who has a background in molecular and cellular biology and has worked in various prestigious research institutions [5] - A co-editor will be based in China, focusing on the field of physical sciences, with details to be announced soon [6] Group 3: Submission Benefits - Authors submitting to Cell Press Blue will engage with high-impact research that can disrupt scientific paradigms, with all papers selected by a professional editorial team from Cell Press [7] - The journal emphasizes a "service-first" philosophy, providing comprehensive support to authors throughout the submission and publication process [8] Group 4: Impact and Promotion - Cell Press Blue aims to promote disruptive scientific research that transcends disciplinary boundaries and contributes to sustainable development [9] - The journal will utilize a professional promotion team to ensure that every published paper receives broad attention and citation [9] Group 5: Additional Features - Collaborative promotion with other relevant Cell Press journals will enhance the visibility of research findings [10] - The journal maintains high standards aligned with other top-tier Cell Press publications, ensuring rigorous quality control [10] - Efficient review processes and direct communication with editors will streamline the publication timeline for authors [10] Group 6: Visibility and Outreach - Targeted marketing activities will significantly enhance the visibility of research published in Cell Press Blue [11] - The journal actively recommends research with news value to mainstream media, helping authors reach a wider audience [11]

Group 1 - The total R&D investment in 2024 is expected to exceed 3.6 trillion yuan [4] - The R&D intensity reached 2.68% in 2020, surpassing the average level of EU countries [5] - The number of high-tech enterprises has increased by 83% compared to 2020, exceeding 500,000 [14] Group 2 - China ranks first globally in the number of "lighthouse factories," accounting for over 40% [19] - The national comprehensive innovation capability ranking improved from 14th in 2020 to 10th in 2024 [10] - Approximately 4 million base stations have been built, maintaining a global lead in technology and user numbers [22] Group 3 - Cumulative sales of new energy vehicles in China have surpassed 4 million, maintaining the global lead for 10 consecutive years [25] - The domestic brain pacemaker has been fully commercialized, helping over 3,000 Parkinson's disease patients improve motor functions [28] Group 4 - China has achieved significant original results in quantum technology, life sciences, and space science, with basic research funding increasing by over 70% [8]